What is the latest STLTECH stock price?
The latest stored price for STLTECH is Rs 818.80 as of 2026-09-18.
gimli
STLTECH stock AI analysis
STLTECH Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
STERLITE TECHNOLOGIES LTD is a small-cap stock in Telecommunication. This Gimli page shows the latest available STLTECH price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹818.80
1W return
-4.21%
1M return
+26.75%
3M return
+26.51%
6M return
+324.05%
1Y return
+564.66%
Market cap
₹39,971.16 cr
PE
164.49
PB
17.62
ROE
+11.42%
ROCE
+12.36%
RSI
62.48
Turnover
₹142.07 cr
Why it can matter in screens
- Momentum: STLTECH is above 50DMA, above 200DMA; RSI is 62.48.
- Returns: 1D -1.05%, 1W -4.21%, 1M +26.75%, 3M +26.51%, 1Y +564.66%.
- Trend levels: 52W high ₹912.00, 52W low ₹492.25, off high -10.22%.
- Liquidity: latest turnover is ₹142.07 cr; volume vs 20D is +0.96%.
- Valuation/profitability: PE 164.49, PB 17.62, ROE +11.42%, ROCE +12.36%.
- Growth: 3Y sales CAGR -11.26%, 3Y profit CAGR -26.49%.
Quick Answers
Is STLTECH above its 50DMA and 200DMA?
STLTECH is above 50DMA, above 200DMA. The latest 50DMA is 651.94 and the latest 200DMA is 364.71.
What are STLTECH PE, ROE and ROCE?
STLTECH has PE 164.49, ROE +11.42%, and ROCE +12.36% in Gimli's latest available snapshot.
How has STLTECH performed recently?
STLTECH has returned +26.75% over 1 month, +26.51% over 3 months, and +564.66% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 1,910.00 cr | 397.00 cr | 197.00 cr | 4.03 |
| 2026-03-31 | 1,441.00 cr | 249.00 cr | 59.00 cr | 1.21 |
| 2025-12-31 | 1,257.00 cr | 114.00 cr | -17.00 cr | -0.35 |
| 2025-09-30 | 1,046.00 cr | 141.00 cr | 4.00 cr | 0.08 |
| 2025-06-30 | 1,019.00 cr | 140.00 cr | 10.00 cr | 0.20 |
| 2025-03-31 | 1,052.00 cr | 146.00 cr | -40.00 cr | -0.84 |
| 2024-12-31 | 998.00 cr | 111.00 cr | -24.00 cr | -0.48 |
| 2024-09-30 | 1,413.00 cr | 151.00 cr | n/a | nan |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 4,745.00 cr | 644.00 cr | 56.00 cr | 1.15 |
| 2025-03-31 | 3,996.00 cr | 467.00 cr | -123.00 cr | -2.54 |
| 2024-03-31 | 4,000.00 cr | 510.00 cr | -51.00 cr | -1.28 |
| 2023-03-31 | 6,790.00 cr | 934.00 cr | 141.00 cr | 3.53 |
| 2022-03-31 | 4,914.00 cr | 777.00 cr | 215.00 cr | 2.04 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 6,346.00 cr | 298.00 cr | 2,213.00 cr | 2,268.00 cr |
| 2025-03-31 | 5,527.00 cr | 396.00 cr | 1,926.00 cr | 1,989.00 cr |
| 2024-03-31 | 8,331.00 cr | 339.00 cr | 3,376.00 cr | 2,023.00 cr |
| 2023-03-31 | 8,865.00 cr | 450.00 cr | 3,834.00 cr | 2,095.00 cr |
| 2022-03-31 | 8,759.00 cr | 411.00 cr | 3,476.00 cr | 2,047.00 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 520.00 cr | 327.00 cr | n/a |
| 2025-03-31 | 348.00 cr | 211.00 cr | n/a |
| 2024-03-31 | 791.00 cr | 511.00 cr | n/a |
| 2023-03-31 | 228.00 cr | -147.00 cr | n/a |
| 2022-03-31 | 584.00 cr | -103.00 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-07-01 | +42.29% | +19.71% | +13.27% | +11.33% | +24.73% | +0.00% |
| 2026-06-30 | +44.51% | +18.22% | +11.44% | +9.48% | +25.83% | +0.00% |
| 2026-03-31 | +44.44% | +11.47% | +10.84% | +7.41% | +33.26% | +0.00% |
| 2025-12-31 | +44.44% | +10.93% | +11.05% | +8.27% | +33.57% | +0.00% |
| 2025-09-30 | +44.45% | +11.28% | +10.79% | +8.04% | +33.48% | +0.00% |
| 2025-06-30 | +44.40% | +6.74% | +11.34% | +8.66% | +37.52% | +0.00% |
| 2025-03-31 | +44.16% | +7.28% | +11.61% | +8.93% | +36.96% | +0.00% |
| 2024-12-31 | +44.17% | +8.71% | +9.43% | +6.57% | +37.70% | +0.00% |
| 2024-09-30 | +44.17% | +8.36% | +10.69% | +7.45% | +36.77% | +0.00% |
| 2024-06-30 | +44.18% | +7.77% | +11.74% | +8.49% | +36.31% | +0.00% |
| 2024-04-12 | +44.19% | +9.97% | +12.46% | +8.43% | +33.38% | +0.00% |
| 2024-03-31 | +53.98% | +5.02% | +2.01% | +0.10% | +38.99% | +0.00% |
| 2023-12-31 | +53.99% | +4.75% | +1.97% | +0.09% | +39.29% | +0.00% |
| 2023-09-30 | +54.00% | +5.45% | +1.94% | +0.07% | +38.61% | +0.00% |
| 2023-06-30 | +54.05% | +7.16% | +2.00% | +0.13% | +36.80% | n/a |
| 2023-03-31 | +54.05% | +8.00% | +2.09% | +0.27% | +35.86% | +0.00% |
| 2022-12-31 | +54.09% | +7.88% | +2.88% | +1.15% | +35.15% | +0.00% |
| 2022-09-30 | +54.11% | +7.92% | +3.78% | +1.31% | +34.19% | n/a |
| 2022-06-30 | +54.15% | +0.00% | +13.20% | n/a | n/a | +0.00% |
| 2022-03-31 | +54.16% | +0.00% | +14.11% | n/a | n/a | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| BHARTIARTL | BHARTI AIRTEL LIMITED | 1,153,121.58 cr | 37.470643 | +17.61% | -2.46% |
| IDEA | VODAFONE IDEA LIMITED | 150,813.50 cr | 4.027299 | -70.60% | +77.55% |
| INDUSTOWER | INDUS TOWERS LIMITED | 99,131.96 cr | 13.857633 | +19.83% | +6.10% |
| BHARTIHEXA | BHARTI HEXACOM LIMITED | 77,005.00 cr | 42.217654 | +27.85% | -9.99% |
| TATACOMM | TATA COMMUNICATIONS LTD | 50,732.85 cr | 54.244069 | +28.02% | +5.73% |
| HFCL | HFCL LIMITED | 33,009.32 cr | 57.244240 | +12.72% | +177.83% |
| ITI | ITI LTD | 24,677.90 cr | 106.443654 | +13.13% | -19.06% |
| TEJASNET | TEJAS NETWORKS LIMITED | 9,195.79 cr | -10.025279 | -27.07% | -15.77% |
Try these prompts
- Analyze STERLITE TECHNOLOGIES with valuation, momentum and industry peers
- Compare STLTECH with other Telecommunication stocks
- Show small-cap stocks in Telecommunication above 50DMA with positive 1M return
- Find Telecommunication stocks with improving momentum and reasonable valuation
Related screen ideas
- View Telecommunication stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare STLTECH with other Telecommunication stocks
Data snapshot: 2026-09-18. Not investment advice.